Higher price of Covaxin in private markets needed to sustain costs: Bharat Biotech

Supply to the government of India at ₹150 per dose is a non-competitive price and clearly not sustainable in the long run, the company said

Comments

Popular posts from this blog

Kannada actor held for smuggling gold worth Rs 12 cr from Dubai

Rahul Dravid’s car hit by goods-laden auto in Bengaluru, video goes viral

Congress groomed me not to sit at home: Shivakumar